U.S., Feb. 25 -- ClinicalTrials.gov registry received information related to the study (NCT07431346) titled 'Prophylactic Intervention for Dysgeusia in Head and Neck Cancer Patients Following Radio(Chemo)Therapy' on Feb. 06.
Brief Summary: Taste changes, also called dysgeusia, affect 56-76% of patients with head and neck cancer treated with radiotherapy (with or without chemotherapy). These taste changes can make eating difficult, lead to weight loss, and reduce quality of life. Despite how common and impactful this problem is, there are very few standardized tools in speech-language therapy to assess or prevent it.
The aim of this study is to develop and test a preventive rehabilitation program for taste function. Eighty patients will be...